Resources - Clinical Practice, Service Delivery and set-up

This section is managed by the Clinical Practice Committee. The current chair is Uma Valeti. If you would like to be part of this committee, please contact him.

a) Information to justify CMR

Indications:
Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report.
CMR utility
MRI Safety:
MRI: safety of cardiovascular devices
Also www.mrisafety.com
Contrast safety:
NSF - see talk below: The Scientific background behind medicolegal aspects of gadolinium and NSF
Training guidelines:
See this page:
Prognostic evidence:
The Prognostic Implications of Cardiovascular Magnetic Resonance
Horizon scanning
Viability (UK) and perfusion (UK) LGE update (Australia).
Cost effectiveness:
CHD diagnosis, The CECaT trial, (old study - pre MR-IMPACT), Economic costs of biological imaging

Appropriateness:
criteria
Standardization:
SCMR standardized imaging protocols
SCMR standardized reporting protocols
Standardize you magnet (members only):
see this page

b) Codes and Tariffs from different countries
USA - see US working group
USA practionners: new CPT codes from 01/2008 (*.doc)
USA practionners: new CPT codes summary from 01/2008 (*.ppt)
UK proposed codes and tariffs - see BSCMR website

c) Draft, generic CMR business case (members only)
(acknowledgement: Dr James Moon. Adapted from the a prior UK business case, with permission, and genericised. This is UK orientatated and written without business training by a clinician in 2007 - use as indicative guide only)
Tables here (Excel - all interlinked), text here:
Note: everything in red needs changing. Use 'find and replace' and change 'Any Hospital' to the name of your Hospital and 'any university' to the name of your University.

d) Lectures - free

Thalassemia: CMR has changed management and outcome - There are some embargoed data in this talk
By Dudley Pennell - Royal Brompton Hospital, UK
Recorded at SCMR 2010

The Scientific background behind medicolegal aspects of gadolinium and NSF
By Martin R Prince - Cornell and Columbia Universities
Recorded at Scmr 2010

LondonCMR - July 2010: Steffen Petersen. CMR for Clinical trials

e) Lectures - members only

SCMR 2010 - Plenary session

A challenge to the CMR community to produce outcomes data for congenital heart disease
By Mark Fogel - Childrens' Hospital of Philadelphia
Recorded at Scmr 2010

Coronary Disease - a Challenge to the CMR community to produce outcomes and cost effectiveness data
By Christopher M Kramer - University of Virginia
Recorded at Scmr 2010

Why outcome data and cost-effectiveness research is critical to cardiac imaging
By Leslee Shaw - Emory University
Recorded at Scmr 2010

Economics, cost effectiveness, medicolegal

Cost-effectiveness with a focus on CMR
By Rory Hatchamovitch - University of Southern California
Recorded at SCMR 2010

History of CMR reinbursement
By Edward T Martin - Oklahoma Heart Institute
Recorded at SCMR 2010

Impact of CMR on patient managerment - european multicenter registry results
By Oliver Bruder - Elizabeth Hospital Essen
Recorded at SCMR 2010

Setting up a Successful Cardiac Imaging Unit
By John Heitner - New York Methodist Hospital
Recorded at SCMR 2010

SCMR 2009
Setting up a successful cardiac imaging unit. Christopher Francois, University of Wisconsin.

Latin American meeting, 2008
Economic Advantages of CMR in Latin America, Juliano Fernandes (Brazil) - talks not in english
Economic Implications of viability assessment with CMR, Ricardo Obregon (Argentina) - talks not in english